FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roland Einarsson

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Concepts & Ideas

Procedures

Immunoassay

Co-author Network

Publications

TOP 3
Rafael Molina; Vivian Barak; Arie Van Dalen; Michael J Duffy; Roland Einarsson; Massimo Gion; Helenka Goike; Rolf Lamerz; Marius Nap; György Sölétormos; Petra Stieber
Tumor markers in breast cancer- European Group on Tumor Markers recommendations.
Vivian Barak; Helena Goike; Katja W Panaretakis; Roland Einarsson
Clinical utility of cytokeratins as tumor markers.
B Slesak; Antonina Harlozinska-Szmyrka; Witold Knast; Pawel Sedlaczek; Roland Einarsson; Arie Van Dalen
TPS and CA 19-9 measurements in the follow-up of patients with pancreatic cancer and chronic pancreatitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roland Einarsson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Rafael Molina; Vivian Barak; Arie Van Dalen; Michael J Duffy; Roland Einarsson; Massimo Gion; Helenka Goike; Rolf Lamerz; Marius Nap; György Sölétormos; Petra Stieber
Tumor markers in breast cancer- European Group on Tumor Markers recommendations.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(6):281-93.
2004: Vivian Barak; Helena Goike; Katja W Panaretakis; Roland Einarsson
Clinical utility of cytokeratins as tumor markers.
Clinical biochemistry 2004;37(7):529-40.
2004: B Slesak; Antonina Harlozinska-Szmyrka; Witold Knast; Pawel Sedlaczek; Roland Einarsson; Arie Van Dalen
TPS and CA 19-9 measurements in the follow-up of patients with pancreatic cancer and chronic pancreatitis.
The International journal of biological markers 2004;19(2):115-9.
2004: Antonina Harlozinska; Pawel Sedlaczek; Jan Kulpa; Marian Grybos; Ewa Wójcik; Arie Van Dalen; Roland Einarsson
Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma.
Anticancer research 2004;24(2C):1149-57.
2002: Pawel Sedlaczek; Irena Frydecka; Marian Gabryś; Arie Van Dalen; Roland Einarsson; Antonina Harłozińska
Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Cancer 2002;95(9):1886-93.
2001: Marius Nap; T van Wel; C Andrés; Laurent Bellanger; H Bodenmüller; H Bonfrer; J Brundell; Roland Einarsson; Ann Erlandsson; Amanda Johansson; J F Leca; T Meier; P Seguin; A Sjödin; Torgny Stigbrand; Birgitta E Sundström; Arie Van Dalen; E Wiebelhaus; B Wiklund; JH Hilgers
Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19. Second report of the TD5 workshop.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(1):4-10.
2000: Arie Van Dalen; J Favier; Alexander Burges; U Hasholzner; HW de Bruijn; D Dobler-Girdziunaite; VH Dombi; D Fink; M Giai; P McGing; Antonina Harlozinska; C Kainz; J Markowska; Rafael Molina; C Sturgeon; A Bowman; Roland Einarsson
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients.
Gynecologic oncology 2000;79(3):444-50.
2000: Arie Van Dalen; J Favier; L Baumgartner; U Hasholzner; HW de Bruijn; D Dobbler; VH Dombi; D Fink; M Giai; P McGing; Antonina Harlozinska; C Kainz; J Markowska; Rafael Molina; C Sturgeon; A Bowman; Roland Einarsson
Serum levels of CA 125 and TPS during treatment of ovarian cancer.
Anticancer research 2000;20(6D):5107-8.
2000: B Slesak; Antonina Harlozinska-Szmyrka; Witold Knast; Pawel Sedlaczek; Arie Van Dalen; Roland Einarsson
Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9.
Cancer 2000;89(1):83-8.
1999: Roland Einarsson; J D Lei; A Ullrich; Arie Van Dalen
Performance characteristics of IMMULITE TPS: a comparison with TPS IRMA.
Anticancer research 1999;19(4A):2743-7.
1999: Arie Van Dalen; J Favier; L Baumgartner; U Hasholzner; HW de Bruijn; D Dobbler; VH Dombi; D Fink; M Giai; P McGing; Antonina Harlozinska; C Kainz; J Markowska; Rafael Molina; C Sturgeon; Roland Einarsson
Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients.
Anticancer research 1999;19(4A):2523-6.
1998: Arie Van Dalen; Vivian Barak; A Cremaschi; M Gion; Rafael Molina; M Namer; P Stieber; C Sturgeon; Roland Einarsson
The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease.
The International journal of biological markers 1998;13(1):10-5.
1998: Torgny Stigbrand; C Andrés; Laurent Bellanger; M Bishr Omary; H Bodenmüller; H Bonfrer; J Brundell; Roland Einarsson; Ann Erlandsson; Amanda Johansson; J F Leca; M Levi; T Meier; Marius Nap; Kjell Nustad; P Seguin; A Sjödin; Birgitta E Sundström; Arie Van Dalen; E Wiebelhaus; B Wiklund; L Arlestig; JH Hilgers
Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19(2):132-52.
1997: A Harłozinska; Pawel Sedlaczek; Arie Van Dalen; K Rozdolski; Roland Einarsson
TPS and CA 125 levels in serum, cyst fluid and ascites of patients with epithelial ovarian neoplasms.
Anticancer research 1997;17(6D):4473-8.